Mitochondrial dysfunction and Alzheimer’s disease: pathogenesis of mitochondrial transfer
In recent years, mitochondrial transfer has emerged as a universal phenomenon intertwined with various systemic physiological and pathological processes. Alzheimer’s disease (AD) is a multifactorial disease, with mitochondrial dysfunction at its core. Although numerous studies have found evidence of...
Saved in:
| Main Authors: | Yun Wei, Xinlei Du, Hongling Guo, Jingjing Han, Meixia Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Aging Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2024.1517965/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction of mitochondrial dysfunction with trimethoxy-substituted monocarbonyl curcumin analogues in experimental Alzheimer’s disease
by: D. I. Pozdnyakov, et al.
Published: (2024-01-01) -
The role of mitochondrial dysfunction in the pathogenesis of Alzheimer’s disease and future strategies for targeted therapy
by: Xin Li, et al.
Published: (2025-05-01) -
The potential of mitochondrial transfer as the modifying therapy for osteoarthritis
by: Yuanpei He, et al.
Published: (2025-08-01) -
Mitochondrial Alterations, Oxidative Stress, and Therapeutic Implications in Alzheimer’s Disease: A Narrative Review
by: Erica Spina, et al.
Published: (2025-02-01) -
Mitotherapy in Alzheimer’s and Parkinson’s diseases: A systematic review of preclinical studies
by: Aynur Modiri, et al.
Published: (2025-05-01)